| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.83T | 1.74T | 1.64T | 1.69T | 1.81T |
| Gross Profit | 774.83B | 683.20B | 603.86B | 641.76B | 768.23B |
| EBITDA | 497.52B | 480.61B | 418.49B | 473.47B | 588.60B |
| Net Income | 233.92B | 233.82B | 180.84B | 243.95B | 314.12B |
Balance Sheet | |||||
| Total Assets | 3.20T | 3.03T | 3.04T | 2.86T | 2.81T |
| Cash, Cash Equivalents and Short-Term Investments | 653.70B | 625.15B | 622.01B | 469.41B | 568.44B |
| Total Debt | 55.77B | 59.99B | 105.94B | 163.57B | 142.98B |
| Total Liabilities | 481.29B | 448.22B | 482.29B | 498.36B | 545.26B |
| Stockholders Equity | 2.72T | 2.58T | 2.56T | 2.36T | 2.26T |
Cash Flow | |||||
| Free Cash Flow | 193.65B | 284.18B | 273.02B | 93.47B | 270.93B |
| Operating Cash Flow | 438.27B | 467.12B | 501.64B | 283.38B | 421.46B |
| Investing Cash Flow | -207.79B | -223.96B | -214.34B | -157.82B | -212.30B |
| Financing Cash Flow | -220.88B | -242.06B | -164.56B | -181.60B | -117.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥710.51B | 15.50 | 8.07% | 2.85% | 9.08% | -8.71% | |
74 Outperform | ¥5.27T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
73 Outperform | ¥9.48T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
67 Neutral | ¥158.27B | 11.45 | ― | 2.18% | -4.77% | -62.32% | |
65 Neutral | ¥771.48B | 15.62 | ― | 2.57% | 5.15% | -47.22% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
51 Neutral | ¥65.38B | 9.09 | 2.26% | ― | 5.14% | 32.69% |